IGI Logo

Aurobindo Pharma is currently trading at Rs. 1453.50, up by 6.35 points or 0.44% from its previous closing of Rs. 1447.15 on the BSE.

The scrip opened at Rs. 1458.80 and has touched a high and low of Rs. 1487.65 and Rs. 1443.00 respectively. So far 35153 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1497.65 on 09-Aug-2024 and a 52 week low of Rs. 815.15 on 05-Sep-2023.

Last one week high and low of the scrip stood at Rs. 1497.65 and Rs. 1396.30 respectively. The current market cap of the company is Rs. 85125.16 crore.

The promoters holding in the company stood at 51.80%, while Institutions and Non-Institutions held 41.50% and 6.70% respectively.

Aurobindo Pharma has reported 2.15% fall in its net profit at Rs 329.04 crore for first quarter ended June 30, 2024 (Q1FY25) as compared to Rs 336.27 crore for the same quarter in the previous year. However, total income of the company increased by 1.58% at Rs 2,525.41 crore for Q1FY25 as compared to Rs 2,486.16 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 61.17% rise in its net profit at Rs 918.22 crore for the quarter ended June 30, 2024 as compared to Rs 569.71 crore for the same quarter in the previous year. Total income of the company increased by 11.79% at Rs 7,787.95 crore for Q1FY25 as compared to Rs 6,966.85 crore for the corresponding quarter previous year.